SEC Form D private-offering filing
Evogene Ltd.
A new SEC Form D private-offering notice from Rehovot, a $3,384,616 filer-stated offering target in Biotech. The source filing is one click away.
Evogene is a Rehovot, Israel based public computational biology company (Nasdaq/TASE: EVGN) using AI driven small molecule design for pharmaceuticals and crop protection.
Filed 2026-02-19Filed to raise $3,384,616First money in 2026-02-11Raised so far $3,384,616HQ (as filed) RehovotSector Biotech ✓Stage (inferred) SeedCall status Needs classification
Source linked the Form D on EDGAR↗Website verified evogene.com↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.